KRT8P39

Across TCGA pan-cancer cohorts, KRT8P39 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated KRT8P39 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher KRT8P39 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated KRT8P39 expression acts as an unfavorable survival marker, although some lineages such as SKCM and STAD show a favorable association.

ACC, LUAD, and MESO are the cancer types where KRT8P39 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	II,III,IV	0.481	0.758	<.001	92	view →
LUAD	DFS	Median	All	0.261	0.431	<.001	54	view →
MESO	OS	Tertile	II,III,IV	0.256	0.523	.001	40	view →
SKCM	DFS	Tertile	All	0.690	0.497	<.001	38	view →
LGG	DFS	Tertile	All	0.649	0.806	<.001	38	view →
KIRC	DFS	Tertile	III,IV	0.320	0.543	.014	36	view →
BLCA	DFS	Tertile	II,III,IV	0.527	0.684	<.001	36	view →
UCEC	DFS	Tertile	All	0.805	0.902	.004	30	view →
LUSC	DFS	Median	II,III,IV	0.523	0.696	.004	26	view →
PAAD	DFS	Tertile	All	0.331	0.576	.003	24	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	23	view →
STAD	OS	Quartile	II,III,IV	0.687	0.483	.011	19	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

KRT8P39–ACC (DFS)

Open the ACC breakdown →